Schoenherr advised MedAustron on the deal.The Austrian cancer treatment and research centre MedAustron obtained the EIA acceptance decision for the fourth treatment room. MedAustron is a…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
